Targeting IL-2 Receptors for Diagnosis and Therapy

Japanese Journal of Clinical Immunology
doi 10.2177/jsci.17.275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society for Clinical Immunology

Related search

Table 2: Anti-Tumor Agents for Targeting Hypoxia-Induced CA IX for Therapy and Diagnosis.

English

Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives With Bombesin, Neurotensin, and Neuropeptide-Y Receptors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

IL-2 Antibodies in Type 1 Diabetes and During IL-2 Therapy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Targeting PVR (CD155) and Its Receptors in Anti-Tumor Therapy

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2018English

Targeting the BCL-2 Family for Cancer Therapy

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2012English

Correction for Krieg Et Al., Improved IL-2 Immunotherapy by Selective Stimulation of IL-2 Receptors on Lymphocytes and Endothelial Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Targeting Β-Cell Functions in Therapy for Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

Novel Targeting Strategies Using Recombinant Antibodies for Early Diagnosis and Therapy of Ovarian Cancer

Therapy
2010English

Lobular Panniculitis After Subcutaneous Administration of Interleukin-2 (IL-2), and Its Exacerbation During Intravenous Therapy With IL-2

British Journal of Cancer
Cancer ResearchOncology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy